CoaguSense received Clinical Laboratory Improvement Amendments (CLIA) Waiver for patient self-testing in the U.S. in 2010, and we have been steadfast in our mission to help people with coagulation ...

MINNEAPOLIS, July 11, 2023 /PRNewswire/ -- ARKRAY USA, Inc., a leader in diabetes and resident care solutions to long-term care facilities, announced today the launch of Assure PT Care PT/INR ...

(HealthDay News) — For hospitalized patients, international normalized ratio (INR) monitoring less frequently than daily is associated with increased odds of warfarin-associated adverse events ...

Research suggests that extending the period between warfarin dose assessments from 4 weeks to 12 weeks is safe for adults receiving long-term, steady doses.

Alere to Initiate Voluntary Withdrawal of the Alere INRatio and INRatio2 PT/INR Monitor System ...

The test strip, PN 99008G2, measures how long it takes blood to clot in patients taking blood thinner warfarin and is used with Alere's INRatio2 PT/INR monitor.